The Justice Department is investigating Abbott Laboratories’ baby formula plant in Michigan, which was at the center of a nationwide formula shortage that plagued millions of families, the Wall Street Journal reports.
In May, Abbott reached an agreement with the Food and Drug Administration (FDA) to reopen the company’s manufacturing plant in Sturgis, Michigan to help ease a nationwide shortage of baby formula, after the facility was closed due to bacterial contamination.
FDA Commissioner Robert Califf said Abbott, under the conditions of the agreement, would correct insanitary conditions that led to the contamination and plant closure.
“The DOJ has informed us of its investigation, and we’re cooperating fully,” an Abbott spokesman told the Wall Street Journal.
The investigation signals further scrutiny of Abbott’s operation of the plant, a major source of baby formula in the U.S.
Last January, FDA inspectors found the cronobacter pathogen at the plant after receiving reports of babies who drank the company’s formula and became sick. The bacteria that was detected in the supply found let to at least four infant illnesses-including two deaths.
KROGER CEO SAYS HALF ITS CUSTOMERS ARE UNDER FINANCIAL STRAIN
The inspectors also found standing water, damage to drying equipment and defects in the seams of formula cans, among other problems at the Sturgis plant.
In a 10-page report published in September, the FDA stated that conditions observed at the Abbott facility “were not consistent with a strong food safety culture.”
Abbott temporarily halted production at the Sturgis factory in February, and recalled baby formula made at the plant.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
The move sparked a national formula shortage which forced the U.S. to airlift millions of pounds of powdered formula from overseas.